However, the COMT gene mutation showed a significant association in acral melanoma (P = 0.016), and the SLC6A4 gene mutation had a significant association in patients with TNM stage 0 or I (P = 0.008). The gene discussed is SLC6A4; the disease is acral lentiginous melanoma.